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Introduction
• Mechanical endovascular reperfusion therapy (MER) is now the standard of
care for treatment of large vessel occlusion (LVO) acute ischemic stroke.

• Nearly 25% of all stroke patients have a recurrent event within 5 years.

But what about recurrent LVO ?

• In 2017 Bosulma et.al studied 697 patients who underwent endovascular, Fifteen
(2%) of treatment for acute ischemic stroke (AIS) over the study period were
treated with RT.

• Successful reperfusion was achieved in 14/15 patients after the first thrombectomy
and in all patients after RT.

• No parenchymal hemorrhage was observed after the first procedure and two were
noted after the repeated intervention.

• The rate of good clinical outcome at 90 days in RT patients was 60% and their 90day mortality rate was only 20%

Methods:
• We conducted case series study of Henry ford health system endovascular
database for patients who underwent RT from March 2016 till March 2018.

• Demographic data, clinical presentation, imaging, procedural data and clinical
outcomes were evaluated.

Results:
• Of the total 145 patients with AIS that received MER, 8 (5.5%) RT occurred
in 5 patients.

•
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Mean age was 67 ± 21 years. Four of the five patients were females.
All five patients achieved successful reperfusion (TICI 2b-3).
Three patients underwent one RT, one had two RT, and one had three RT.
Cardio-embolic source (80%) was the most common etiology and ESUS
etiology was (20%).

Results cont.
• The time between the first to last MER for each patient ranged from 3 days to 2 years.
• All patients were optimized on their medical therapy after the first stroke.
• Four of the five patients (80%) had RT in the same vascular territory.

• One patient had post-procedure focal high-grade stenosis after the 3rd intervention in the same
artery that was treated later with elective angioplasty.

• One RT was complicated with fatal intracranial hemorrhage due to late presentation despite
presence of large area of penumbra.

• Average 3 months follow up MRS was 2.

Conclusion:
• In patients presented with recurrent LVO, RT appears to be effective and relatively
safe. Based on the available literature, prior MER should not discourage aggressive
treatment that may potentially lead to a good clinical outcome.

• It is unclear if prior MER therapies cause endothelial injury leading to a predilection
for local in-situ thrombus or denovo stenosis formation predisposing to reocclusions.

• The risk of reperfusion injury in a recently infarcted territory should be weighted
carefully when considering as hemorrhagic complications remain possible.
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